Ablation of C9orf72 together with excitotoxicity induces ALS in rats

被引:15
|
作者
Dong, Wei [1 ,2 ]
Ma, Yuanwu [2 ,3 ]
Guan, Feifei [1 ]
Zhang, Xu [3 ]
Chen, Wei [1 ]
Zhang, Li [3 ]
Zhang, Lianfeng [1 ,2 ]
机构
[1] Chinese Acad Med Sci, Key Lab Human Dis Comparat Med, Natl Hlth Commiss China NHC, Inst Lab Anim Sci,Peking Union Med Coll, Bldg 5, Beijing 100021, Peoples R China
[2] Chinese Acad Med Sci, Neurosci Ctr, Beijing, Peoples R China
[3] Chinese Acad Med Sci, Peking Union Med Coll, Beijing Engn Res Ctr Expt Anim Models Human Dis, Inst Lab Anim Sci, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
ALS; C9orf72; excitotoxicity; kainic acid; knockout; rat; AMYOTROPHIC-LATERAL-SCLEROSIS; DIPEPTIDE-REPEAT PROTEINS; KAINIC ACID; FRONTOTEMPORAL DEMENTIA; MOUSE MODEL; RNA FOCI; HEXANUCLEOTIDE REPEAT; MOTOR-NEURONS; GGGGCC REPEAT; EXPANSION;
D O I
10.1111/febs.15501
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Pathogenesis of familial amyotrophic lateral sclerosis (ALS) linked to expansion of the chromosome 9 open reading frame 72 (C9orf72) hexanucleotide repeat that impairs C9orf72 expression. Loss of function of the C9orf72 protein is one of the three main proposedC9orf72-related ALS mechanisms. However,C9orf72loss of function, by itself, is insufficient to cause severe phenotypes in mice. Excitotoxicity is another major disease mechanism of ALS. We speculate that loss of C9orf72 protein might cause ALS in combination with excitotoxicity. To date, the effect of C9orf72 deficiency in the background of SD rat has not been examined. To test our hypothesis, we generated a line of rat with a deletion of part of theC9orf72gene ablating the encoded protein. These animals did not develop any ALS phenotypes; however, when they were treated with kainic acid, an excitotoxicity inducer, the rats developed motor deficits and showed loss of motor neurons (MNs), Golgi complex fragmentation, and abnormal vesicle trafficking. RNA sequencing revealed profound changes in the gene profiles that were primarily associated with neural activity. Our results demonstrated that C9orf72 ablation alone was not enough to cause ALS pathogenesis in rat; but the ablation sensitized MNs to other risk factors that synergistically caused the ALS. These results support a loss of function ofC9orf72mechanism of ALS.
引用
收藏
页码:1712 / 1723
页数:12
相关论文
共 50 条
  • [1] Knock in of a hexanucleotide repeat expansion in the C9orf72 gene induces ALS in rats
    Dong, Wei
    Zhang, Li
    Sun, Caixian
    Gao, Xiang
    Guan, Feifei
    Li, Jing
    Chen, Wei
    Ma, Yuanwu
    Zhang, Lianfeng
    ANIMAL MODELS AND EXPERIMENTAL MEDICINE, 2020, 3 (03) : 237 - 244
  • [2] Novel clinical associations with specific C9ORF72 transcripts in patients with repeat expansions in C9ORF72
    van Blitterswijk, Marka
    Gendron, Tania F.
    Baker, Matthew C.
    DeJesus-Hernandez, Mariely
    Finch, NiCole A.
    Brown, Patricia H.
    Daughrity, Lillian M.
    Murray, Melissa E.
    Heckman, Michael G.
    Jiang, Jie
    Lagier-Tourenne, Clotilde
    Edbauer, Dieter
    Cleveland, Don W.
    Josephs, Keith A.
    Parisi, Joseph E.
    Knopman, David S.
    Petersen, Ronald C.
    Petrucelli, Leonard
    Boeve, Bradley F.
    Graff-Radford, Neill R.
    Boylan, Kevin B.
    Dickson, Dennis W.
    Rademakers, Rosa
    ACTA NEUROPATHOLOGICA, 2015, 130 (06) : 863 - 876
  • [3] RNA-mediated toxicity in C9orf72 ALS and FTD
    McEachin, Zachary T.
    Parameswaran, Janani
    Raj, Nisha
    Bassell, Gary J.
    Jiang, Jie
    NEUROBIOLOGY OF DISEASE, 2020, 145
  • [4] G-quadruplex-binding small molecules ameliorate C9orf72 FTD/ALS pathology in vitro and in vivo
    Simone, Roberto
    Balendra, Rubika
    Moens, Thomas G.
    Preza, Elisavet
    Wilson, Katherine M.
    Heslegrave, Amanda
    Woodling, Nathan S.
    Niccoli, Teresa
    Gilbert-Jaramillo, Javier
    Abdelkarim, Samir
    Clayton, Emma L.
    Clarke, Mica
    Konrad, Marie-Therese
    Nicoll, Andrew J.
    Mitchell, Jamie S.
    Calvo, Andrea
    Chio, Adriano
    Houlden, Henry
    Polke, James M.
    Ismail, Mohamed A.
    Stephens, Chad E.
    Vo, Tam
    Farahat, Abdelbasset A.
    Wilson, W. David
    Boykin, David W.
    Zetterberg, Henrik
    Partridge, Linda
    Wray, Selina
    Parkinson, Gary
    Neidle, Stephen
    Patani, Rickie
    Fratta, Pietro
    Isaacs, Adrian M.
    EMBO MOLECULAR MEDICINE, 2018, 10 (01) : 22 - 31
  • [5] RNA dependent suppression of C9orf72 ALS/FTD associated neurodegeneration by Matrin-3
    Ramesh, Nandini
    Daley, Elizabeth L.
    Gleixner, Amanda M.
    Mann, Jacob R.
    Kour, Sukhleen
    Mawrie, Darilang
    Anderson, Eric N.
    Kofler, Julia
    Donnelly, Christopher J.
    Kiskinis, Evangelos
    Pandey, Udai Bhan
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2020, 8 (01)
  • [6] There has been an awakening: Emerging mechanisms of C9orf72 mutations in FTD/ALS
    Gitler, Aaron D.
    Tsuiji, Hitomi
    BRAIN RESEARCH, 2016, 1647 : 19 - 29
  • [7] The Enigmatic Role of C9ORF72 in Autophagy
    Nassif, Melissa
    Woehlbier, Ute
    Manque, Patricio A.
    FRONTIERS IN NEUROSCIENCE, 2017, 11
  • [8] Moderate intrinsic phenotypic alterations in C9orf72 ALS/FTD iPSC-microglia despite the presence of C9orf72 pathological features
    Lorenzini, Ileana
    Alsop, Eric
    Levy, Jennifer
    Gittings, Lauren M.
    Lall, Deepti
    Rabichow, Benjamin E.
    Moore, Stephen
    Pevey, Ryan
    Bustos, Lynette M.
    Burciu, Camelia
    Bhatia, Divya
    Singer, Mo
    Saul, Justin
    McQuade, Amanda
    Tzioras, Makis
    Mota, Thomas A.
    Logemann, Amber
    Rose, Jamie
    Almeida, Sandra
    Gao, Fen-Biao
    Marks, Michael
    Donnelly, Christopher J.
    Hutchins, Elizabeth
    Hung, Shu-Ting
    Ichida, Justin
    Bowser, Robert
    Spires-Jones, Tara
    Blurton-Jones, Mathew
    Gendron, Tania F.
    Baloh, Robert H.
    Van Keuren-Jensen, Kendall
    Sattler, Rita
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2023, 17
  • [9] Biomarker development for C9orf72 repeat expansion in ALS
    Mendez, Emily F.
    Sattler, Rita
    BRAIN RESEARCH, 2015, 1607 : 26 - 35
  • [10] Oligogenicity, C9orf72 expansion, and variant severity in ALS
    Ross, Jay P.
    Leblond, Claire S.
    Laurent, Sandra B.
    Spiegelman, Dan
    Dionne-Laporte, Alexandre
    Camu, William
    Dupre, Nicolas
    Dion, Patrick A.
    Rouleau, Guy A.
    NEUROGENETICS, 2020, 21 (03) : 227 - 242